Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-439,659
Closed -$3.11M 145
2025
Q3
$3.11M Buy
439,659
+13,444
+3% +$110K 0.07% 64
2025
Q2
$3.86M Buy
426,215
+383,529
+898% +$3.71M 0.12% 48
2025
Q1
$398K Buy
42,686
+19,005
+80% +$259K 0.01% 49
2024
Q4
$281K Buy
23,681
+21,319
+903% +$286K 0.01% 50
2024
Q3
$37.1K Sell
2,362
-214
-8% -$2.99K ﹤0.01% 73
2024
Q2
$34.5K Sell
2,576
-4,688
-65% -$65K ﹤0.01% 67
2024
Q1
$96K Hold
7,264
﹤0.01% 57
2023
Q4
$99K Sell
7,264
-2,384
-25% -$23.6K ﹤0.01% 56
2023
Q3
$79K Sell
9,648
-1,711
-15% -$15.9K ﹤0.01% 57
2023
Q2
$108K Sell
11,359
-231
-2% -$2.04K ﹤0.01% 49
2023
Q1
$116K Buy
+11,590
New +$102K ﹤0.01% 46

Other funds holding SEMR

Antipodes Partners's SEMR Position: Q4 2025 in Review

Antipodes Partners sold out of Semrush (SEMR) in Q4 2025, closing a stake of 439,659 shares — an estimated $3.11M sold.

Antipodes Partners first reported a position in SEMR in Q1 2023 and held it in 11 quarters. The position peaked at $3.86M in Q2 2025. 165 funds tracked by Wall St. Rank hold SEMR as of Q4 2025.

  • Antipodes Partners reported no remaining Semrush position as of Q4 2025 after selling out during the quarter.
  • Antipodes Partners sold 439,659 Semrush shares in Q4 2025, an estimated $3.11M.
  • Antipodes Partners first reported a position in Semrush in Q1 2023 and held it in 11 quarters.
  • Antipodes Partners's Semrush position peaked at $3.86M in Q2 2025.
  • 165 funds tracked by Wall St. Rank held Semrush as of Q4 2025.

Based on Antipodes Partners's 13F filing for Q4 2025, filed 5 Feb 2026.